Lay understanding of cancer genetics activities in the UK
Lay understanding of cancer genetics activities in the UK
PURPOSE: This multidisciplinary project investigates
healthcare professionals’, patients’ and regulators’/
stakeholders’ understandings of cancer
genetics activities within the UK. It looks at how
these groups conceive the research–clinical practice
distinction, and aims to identify any perceived
ambiguities, whether practical and/or ethical problems
that are generated for the different actors.
METHODS: Semi-structured interviews with
healthcare professionals who are involved in cancer
genetics research and/or provide a clinical cancer
genetics service; patients attending cancer genetics
clinics who are a cross-section of those involved in
research (DNA e.g. Familial Breast Cancer Study
and/or clinical studies e.g.: UKFOCSS, CAPP2),
refused or not invited to participate in research and
regulators who play a role in the regulation of
clinical research or clinical practice. This paper
reports data from the patient interviews (n ¼ 35).
RESULTS: The data suggests that many patients
fail to distinguish clinical care from research. Some
perceive clinical services as research and vice versa.
Many patients are unaware that they have been
recruited to research protocols and fail to recall
consent procedures in any detail. Research experienced
relates to the variation reported in the
understanding of research–clinical practice boundaries.
While they feel informed consent is important
and should be sought, they often report the
associated procedures do not reflect the type of
research they are involved with. CONCLUSIONS:
As far as many patients are concerned, the
research–clinic boundary within cancer genetics is
ambiguous. The implications for informed consent
and ways in which this could be better managed
will be discussed.
265-265
Cooke, S
de6ba8be-f6bc-48ad-b713-0c0b1d59aeea
Lucassen, A
2eb85efc-c6e8-4c3f-b963-0290f6c038a5
Crawford, G
c49ec103-2936-4897-8f25-96abe25b3a9f
Parker, M
d012a2b8-d4f7-49c1-beca-d69705c2ee43
Hallowell, N
a0206c14-40c8-4bbe-9a57-65a74f6d3f7c
21 February 2007
Cooke, S
de6ba8be-f6bc-48ad-b713-0c0b1d59aeea
Lucassen, A
2eb85efc-c6e8-4c3f-b963-0290f6c038a5
Crawford, G
c49ec103-2936-4897-8f25-96abe25b3a9f
Parker, M
d012a2b8-d4f7-49c1-beca-d69705c2ee43
Hallowell, N
a0206c14-40c8-4bbe-9a57-65a74f6d3f7c
Cooke, S, Lucassen, A, Crawford, G, Parker, M and Hallowell, N
(2007)
Lay understanding of cancer genetics activities in the UK.
Psycho-Oncology, 16 (3), .
(doi:10.1002/pon.1165).
Abstract
PURPOSE: This multidisciplinary project investigates
healthcare professionals’, patients’ and regulators’/
stakeholders’ understandings of cancer
genetics activities within the UK. It looks at how
these groups conceive the research–clinical practice
distinction, and aims to identify any perceived
ambiguities, whether practical and/or ethical problems
that are generated for the different actors.
METHODS: Semi-structured interviews with
healthcare professionals who are involved in cancer
genetics research and/or provide a clinical cancer
genetics service; patients attending cancer genetics
clinics who are a cross-section of those involved in
research (DNA e.g. Familial Breast Cancer Study
and/or clinical studies e.g.: UKFOCSS, CAPP2),
refused or not invited to participate in research and
regulators who play a role in the regulation of
clinical research or clinical practice. This paper
reports data from the patient interviews (n ¼ 35).
RESULTS: The data suggests that many patients
fail to distinguish clinical care from research. Some
perceive clinical services as research and vice versa.
Many patients are unaware that they have been
recruited to research protocols and fail to recall
consent procedures in any detail. Research experienced
relates to the variation reported in the
understanding of research–clinical practice boundaries.
While they feel informed consent is important
and should be sought, they often report the
associated procedures do not reflect the type of
research they are involved with. CONCLUSIONS:
As far as many patients are concerned, the
research–clinic boundary within cancer genetics is
ambiguous. The implications for informed consent
and ways in which this could be better managed
will be discussed.
This record has no associated files available for download.
More information
Published date: 21 February 2007
Identifiers
Local EPrints ID: 62709
URI: http://eprints.soton.ac.uk/id/eprint/62709
PURE UUID: a7637e12-c403-45db-bfe5-303c690f8959
Catalogue record
Date deposited: 10 Sep 2008
Last modified: 16 Mar 2024 03:23
Export record
Altmetrics
Contributors
Author:
S Cooke
Author:
M Parker
Author:
N Hallowell
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics